Browsing Tag
UK
43 posts
Israel halts Gaza aid flotilla but activists say one vessel slipped through blockade
Israel intercepts most of a Gaza aid flotilla, but one ship reportedly breached the blockade. Find out what this means for law, diplomacy, and activism.
AbbVie’s bold gamble: Can Elahere really launch in the UK at full U.S. list price?
AbbVie plans to launch ovarian cancer drug Elahere in UK at U.S. price—testing NICE, NHS, and investor confidence in oncology pricing norms.
Lupin deepens specialty push with VISUfarma acquisition: Can ophthalmology power its next European chapter?
Lupin acquires VISUfarma to expand into Europe’s ophthalmology market. Find out how this deal could reshape its specialty growth strategy.
Innovent Biologics secures FDA greenlight for first global Phase 3 trial of IBI363 in lung cancer
Innovent Biologics wins FDA approval for its first global Phase 3 trial of IBI363 in lung cancer, signaling a major milestone in immuno-oncology.
Guidehouse secures eight-Lot win on Crown Commercial Service MCF4 framework, strengthening public sector transformation presence in the UK
Guidehouse wins eight Lots on UK’s CCS MCF4 framework, the highest of any firm, boosting its role in public sector transformation and innovation.
XCMG expands European partner ecosystem with electrification, smart tech, and logistics investments across Germany, Turkey, and the UK
XCMG (SHE:000425) advances its "In Europe, For Europe" strategy through new electrification, logistics, and intelligent tech partnerships in Germany, Turkey, and the UK.
Intralot to acquire Bally’s digital gaming unit in €2.7bn deal to build global lottery leader
Find out how Intralot’s €2.7B acquisition of Bally’s interactive business could reshape global lottery and iGaming strategy in Europe and North America.
Vodafone stock surges 7% after FY25 results highlight strategic turnaround, buyback program, and UK-Africa growth engine
Vodafone stock jumps 7% after FY25 results show strong cash flow, €2B buyback, UK-Africa growth. See what’s driving the bullish turnaround.
Victoria PLC sees EBITDA margin rebound in FY2025 as flooring recovery gathers pace
Victoria PLC targets £1.11 billion FY2025 revenue with margin expansion and refinancing in focus amid tariff risk and investor repositioning.
BP signals weak Q1 2025 gas trading and $4bn debt jump despite strong refining margins
BP forecasts weak Q1 2025 gas trading and $4B debt rise despite strong refining margins. Find out how this impacts its stock performance and investor outlook.